August AI announces physician-reviewed prescription renewal pilot in Utah
Published in Artificial Intelligence, Tools.
On October 5, 2026, August AI announced authorization to pilot AI-assisted prescription renewals for Utah patients with chronic conditions. The company says renewals will cost $4 each and that a Utah-licensed physician will review and authorize every prescription.
The AI prepares a renewal recommendation for routine, non-controlled medicines, including common treatments for diabetes and cardiovascular disease. The pilot concerns continuing existing treatment; it does not authorize new prescriptions, dose changes or medication substitutions.
Utah’s official pilot record lists an agreement signed October 2, 2026. It requires physician review before the first 250 refills, retrospective review of the next 1,000, and state permission for each new phase. Identity and pharmacy-record verification, escalation of concerning cases, pharmacist disclosure and adverse-event reporting are also required.
The company announcement presents a physician-led model even though the agreement permits later review phases under conditions. Sandbox participation is a limited regulatory arrangement, not proof of clinical effectiveness or a state endorsement.
Sources: August AI announcement, October 5, 2026; Utah official pilot record, agreement signed October 2, 2026.